Adverse event

/Tag:Adverse event

EFFICACY AND SAFETY OF REVEFENACIN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS NOT AGE DEPENDENT: A POST HOC SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS

Background: Revefenacin (REV), a once-daily, long-acting muscarinic antagonist for nebulized inhalation, was recently approved for maintenance treatment of chronic obstructive pulmonary disease (COPD). We present post hoc efficacy and safety data from three phase 3 [...]

By | 2019-03-11T14:18:44+00:00 March 11th, 2019|Hospital Medicine 2019, Other, Research|Comments Off on EFFICACY AND SAFETY OF REVEFENACIN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS NOT AGE DEPENDENT: A POST HOC SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS

THROMBOEMBOLIC AND BLEEDING EVENTS AFTER ANTICOAGULANT INTERRUPTION IN PATIENTS WITH MECHANICAL HEART VALVE HOSPITALIZED FOR EMERGENCY/URGENT NON-CARDIAC SURGERY

Background: Perioperative management of anticoagulant in mechanical valve patients is challenging, Current recommendations focus on management in patients undergoing elective surgery, while the data in patients hospitalized for emergency/urgency non-cardiac surgery is limited. We aimed [...]

By | 2019-03-11T14:22:06+00:00 March 11th, 2019|Hospital Medicine 2019, Perioperative, Research|Comments Off on THROMBOEMBOLIC AND BLEEDING EVENTS AFTER ANTICOAGULANT INTERRUPTION IN PATIENTS WITH MECHANICAL HEART VALVE HOSPITALIZED FOR EMERGENCY/URGENT NON-CARDIAC SURGERY